Danish analytical technology specialist Foss has reported a sharp
increase in organic growth in 2004, helped in part by the merger of
two of Foss subsidiaries, and the introduction of 10 new products
for the world market, reports...
Faced with a raft of consolidation in the market for generic
pharmaceuticals, Germany's Merck KGaA has entered the fray with an
agreement to acquire most of NM Pharma, the Scandinavian generics
business of top drugmaker Pfizer.